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mean age for the entire obese sub-sample was 54.8 (o15.5), compared to 45,8 (   o18,4) 
for the non-obese participants. 40.4% of the obese participants suffered from at least 
one comorbid disease such as hypertension, diabetes, hyperlipidaemia, compared to a 
much lower 21.1% for the remaining sample. The unadjusted SF-12 scores for obese 
and non-obese participants were: PCS 44.9 ( o12.0) and 50.5 (  o9.8) (Mann-Whitney, 
P  0.001) and MCS 45.8 (o10.1) KAI 49.6 (o 8.9) (Mann-Whitney, P  0.001). After 
adjusting for confounding variables, the respective scores were PCS 48.2 and 49.8   
(P  0.05, R2  37.9%), and MCS 47.1 and 49.3 (      P  0.01, R2  9.7%) respectively. 
CONCLUSIONS: Obesity signiﬁcantly affects physical and mental health. Recogniz-
ing the serious impact on health and HRQoL, and on the raising health care cost as 
well, formulating effective strategies to prevent obesity should become major public 
health priorities.
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OBJECTIVES: Obesity is a major risk factor for a number of chronic diseases, includ-
ing diabetes, cardiovascular diseases and cancer. Obesity and its comorbidities signiﬁ-
cantly depress patients quality of life. The aim of this study was to estimate the impact 
of obesity on quality of life in Polish population. METHODS: The 20-item WRSM 
(Weight-Related Symptom Measure) and EQ-5D (EuroQol) questionnaires as well 
VAS (visual analogue scale) were used to asses Qol in obese patients (BMI  30 kg/m2), 
treated in National Food and Nutrition Institute in Warsaw. We used EQ-5D Polish 
TTO-value set to estimate health uitlity. EQ-5D utility and VAS were compared to 
previously published Polish population norms (age speciﬁc for EQ-5D or age and sex 
speciﬁc for VAS). Data are presented as mean (SD). RESULTS: Data on 68 obese 
patients are available with 18 (26.5%) being severely obese (BMI  40). The mean 
age of observed population was 52.6 (12.6) years and mean BMI was calculated at 
37.2 (6.6) kg/m2. The mean state of health recorded on the visual analogue scale was 
72.6 (15.3). The mean utility value (EQ-index) was estimated at 0.868 (0.154). The 
mean WRSM value was estimated at 16.9 (16.6). The mean utility value was compa-
rable to age speciﬁc data (based on population with BMI  26.2) - 0.899; p  0.282, 
however mean VAS was signiﬁcantly (p  0.003) lower to this estimated based on age 
and sex speciﬁc norms (78.5 in a given population). There were weak correlations 
between BMI and either EQ-index (R2  0.11), VAS (R2  0.14) or WRSM (R2  0.15). 
Population of patients with severe obesity (BMI  40) had signiﬁcantly lower EQ-index 
and VAS and signiﬁcantly higher WRSM compared to the rest of obese population 
(p  0.044; 0.046 and 0.016 respectively). CONCLUSIONS: Obesity has signiﬁcant 
negative impact on patients quality of life. There is no straightforward correlation 
between BMI and QoL indices.
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OBJECTIVES: This part of DEFI study aimed at assessing Qol in a FM population 
whose diagnosis was suspected or clinically conﬁrmed. METHODS: In a French cross-
sectional study, 6000 subjects were screened by phone using the French validated 
London Fibromyalgia Epidemiological study Screening Questionnaire (LFES-SQ) 
which was positive for 232 of them (LFES-SQ). On this population 145 accepted to 
ﬁll in SF36 and were proposed a rheumatologist consultation : 49 refused but ﬁlled 
in questionnaires, 20/96 who accepted the consultation and questionnaires (CS) were 
diagnosed as FM (FM) on the ACR criteria. RESULTS: Normalized SF36 subscales 
mean values of LFES-SQ subjects are as follow: Physical Functioning (PF) 42.3 o 
10.4, Role Physical (RP) 36,8 o 9.4, Bodily Pain (BP) 42,5 o 7.1, General Health (GH) 
39,9 o 9.6, Vitality (VT) 41.3 o 6.6, Social Functioning (SF) 43.5 o 9,4, Role Emo-
tional (RE) 43,7 o 9,4 , Mental Health (MH) 36,8 o 7.4. Physical component score 
(PCS) was 42.4 o 8.4 while mental component score (MCS) was 40.0 o 9.5. No sig-
niﬁcant differences were observed between CS and CS- subjects. In contrast, com-
parisons between the FM and FM- subjects showed in most cases signiﬁcant 
differences : PF 37.7 o 8.1 vs 44.6 o 9.4 (p  0.003), RP 33.6 o 5.4 vs 36.9 o 10.0 
(p  0.053), BP 39.6 o 6.0 vs 43.5 o 6.1 (p  0.011), GH 33.2 o 8.2 vs 42.3 o 9.0 
(p  0.0001), VT 39.2 o 4.2 vs 44.7 o 6.3 (p  0.0001), SF 39.0 o 8.3 vs 45.8 o 
9.3 (p  0.004), RE 33.2 o 11.3 vs 44.9 o 14.1 (p  0.027), MH 33.5 o 5.2 vs 37.6 
o 7.2 (p  0.019), PCS 38.2 o 7.0 vs 43.6 o 7.8, (p  0.006), MCS 35.3 o 7.5 vs 41.6 
o 9.4 (p  0.008). CONCLUSIONS: This study demonstrated the alterations of SF36 
in positive screened and ACR criteria conﬁrmed FM subjects.
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OBJECTIVES: To assess potential individual factors inﬂuencing quality of life and 
pain scores of patients suffering from histologically conﬁrmed endometriosis. Study 
using a questionnaire among patients of reproductive age undergoing laparoscopy       
with a presumed diagnosis of endometriosis. METHODS: Details of fertility, previous 
treatments and quality of life, sexual activity, as well as linear pain scores for several 
symptoms, were recorded. Details of intraoperative ﬁndings were also collected and 
only those data were used where endometriosis was intraoperatively and histologically 
proven. A questionnaire before surgery gathered information from women on the          
following groups of variables: age, marital status, education, reproductive and medical 
history including previous pregnancies and parity, knowledge of accompanying pelvic 
disorders, regular sport activity, as well as general quality of life estimates including 
self-image. Pelvic pain was scored using a visual analogue scale. RESULTS: Eighty-one 
patients complaining about persistent pelvic pain were later intraoperatively and his-
tologically proven to have endometriosis. Thirty-one of them (38.2%) reported regular 
sport as part of their daily life schedule while 50 of them (61,8%) performed no 
physical activity at all. Fourteen patients among regular exercisers and 33 patients 
among those without physical activity reported the effectiveness of painkillers for 
pelvic pain, corresponding to 45.1% and 66% of these subgroups, respectively (dif-
ference statistically signiﬁcant, p  0.05). CONCLUSIONS: Based on our results, we 
can conclude, that taking painkillers might be less effective among endometriosis 
patients performing regular daily sport activities, and, thus it might impose them to 
an unnecessary burden of possible side effects.
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OBJECTIVES: To estimate effectiveness of enzyme replacement therapy (ERT) in the 
treatment of symptomatic Gaucher’s disease in the Ural’s cohort in Russia. METHODS: 
Information sources were the databases of regional registries in 3 big towns of Ural 
administration District of Russian Federation: Ekaterinburg, Perm, Chelyabinsk, 
updated January 2009. Most of the parameters were derived from the published lit-
erature. Doses of Cerezymeare varies from 1200 un. till 2000 un. ERT was assumed 
to restore patients to full health in the base case. Regional cohort include 21 patients, 
middle age 23 years old. Quality of life was tested by Short Form 36 (SF-36). 
RESULTS: Seventy percent of the patients were diagnosed in childhood and have 1 
type Gaucher Disease. The clinic characteristics were typical. Bone abnormalities were 
the most serious. Data on this topic were obtained from the primary medical sources. 
The mean cost of the disease calculated about a120,000. The cost per patient varied 
considerably by dose. Nonetheless , quality of life indicate that patients treated with 
ERT continue to have reduced health-related quality of life 0.5 compared with the 
general population 0.75. And as much more younger seriously sick patients started 
ERT-quality of life index could be higher. The social efﬁcacy of ERT equivalent extra 
number of life years, in this cohort it’s about 13.7 years.Economic evaluations were 
found, all of which calculated a very high cost per quality-adjusted life-year (QALY). 
Incremental cost per QALY incremental cost-effectiveness ratio (ICER) in the base 
case a210,000. CONCLUSIONS: Although ERT for treating the ‘average’ Gaucher’s 
disease patient supported by the national program for orphan diseases, despite of it 
great expense. However, although doing so will be of clinical interest, it is questionable 
whether, within the current pricing environment, such research would have any sub-
stantive impact on policy decisions.
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OBJECTIVES: New recommendations were elaborated in April 2008 in France 
regarding overdoses, situations of hemorrhagic risk and bleeding accidents occurring 
in patients treated with vitamin-K antagonists (VKA). Considering the necessity for 
hospitals to guarantee the good therapeutic use of drugs to obtain reimbursement by 
public health insurance, and with the signiﬁcant increase of prescriptions in 2008, a 
systematic follow-up of correspondence between prothrombin complex concentrates 
use (PCC, Kaskadil®) and current guidelines was analyzed. METHODS: A prospec-
tive study of patients treated with PCC in 2008 was conducted. Data collected 
included demographic, therapeutic (indication, dosage), biological (INR, PT), clinical 
(bleeding, surgery . . .) and pharmacoeconomic parameters. Results are expressed as 
median and interquartile range (IQR 25–75). RESULTS: Ninety-one patients (41 men, 
median age: 76 years) received PCC, namely 78.4% compared to 2007, for a total 
cost of a81 K (73%). Analysis of prescriptions reveals that indications corresponded 
to the marketing authorisation (MA): 36% of bleeding under VKA, 30% of urgent 
surgery or invasive procedure and 29% of overdose (INR  5). Fluindione was the 
mainly prescribed VKA (77%). Median values of INR were 4 (2.9–6.9) and PT 33.5% 
(24–54%). Median doses of PCC were in accordance with MA and recommendations: 
